Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Angelman syndrome antisense treatment

US Patent 12180480 · Granted Dec 31, 2024

Estimated economic value: $525,543,000

Assignee

Inventors

View full patent text on Google Patents →